You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Blood Glucose Articles
Popular Blood Glucose Articles
Highly Recommended Blood Glucose Articles
Send a link to this page to your friends and colleagues.
In people with higher A1Cs, rapid-acting insulin analogs NovoLog (insulin aspart) and Humalog (insulin lispro) are more effective in achieving optimal blood glucose control when administered with insulin pumps rather than via multiple daily insulin injections (MDII), according to University of Toronto researchers.
“A model derived from these data predicts that in a patient with a baseline A1C of 10%, [rapid-acting insulin in pumps] would reduce the A1C by an additional 0.65% compared with MDII,” write the researchers. On the other hand, there would be no A1C benefit to using rapid-acting insulin in pumps, compared with MDII, if baseline A1Cs were 6.5%.
The researchers conclude that using fast-acting insulin in pumps may be uniquely advantageous in adults with type 1 diabetes and poor blood glucose control.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.